Download Technical Paper.
Read Technical Paper
View the ePUR Solutions Sell Sheet.
View Sell Sheet
View JLS Envirocooler ePUR Press Release.
View Press Release
Featured
Featured posts
Jarden Life Sciences is excited to be a sponsor of this year’s Cold Chain GDP & Temperature Management Logistics Global Forum!
Visit us at BOOTH 116, September 28- 29, 2016 at the John B. Hynes Convention Center to learn about some of the industry’s latest innovation in cold chain and how you can benefit from it!
Connect with us before the show or set up an appointment:
The World’s Largest Event for Temperature Controlled Life Science Supply Chains
New York, NY – Jarden Life Sciences recently announced they are once again proudly sponsoring the 14th Annual Cold Chain GDP & Temperature Management Logistics Global Forum. Jarden Life Sciences will be joined by 850 temperature controlled life science leaders, September 26-30 at the Hynes Convention Center in Boston, MA.
In its 14th installment, the Cold Chain Global Forum has significantly expanded the topic focuses, session formats, speaking faculty and vendor options to help meet the industry’s emerging and ongoing challenges for 2016 and beyond. This year over 120 speakers and over 120 sponsors and exhibitors will explore cost-reduction strategies, upcoming and changing industry standards and risk management that will help companies ensure maximum compliance, quality and product integrity.
This year’s impressive line-up of speakers includes Steve Todd, Senior GDP Inspector at MHRA; Christopher Wallace, Senior Director, International Supply Chain Operations at Sanofi Genzyme; Terry Carrico, VP Corporate Security & Safety at McKesson; Bill McGillian, Associate Director, Logistics at Merck; and Rajesh Pednekar, Head of Distribution at Pfizer India; to name a few.
The event is designed to include eight pre-conference workshops, two in-depth master classes, two days of main conference sessions, roundtable discussions & panel discussions, and more than 14 hours of networking to discuss the most important challenges and most effective strategies and solutions within the cold chain industry.
Jarden Life Sciences will be featured in the comprehensive expo hall, that’s showcasing the most innovative technologies and solutions in the industry. Jarden Life Sciences, a leader in the design of thermal packaging solutions, has a diverse capability developing customized primary and secondary packaging as well as delivery of off-the-shelf solutions which makes them an invaluable partner.
“We’re thrilled to head back to Boston once again for the Cold Chain Global Forum,” said Claudia Rubino, Divisional Director – Cold Chain Portfolio, IQPC. “The Global Forum continues to be the leading event for temperature-controlled life science supply chains, and we’re pleased to have Jarden Life Sciences partner with us to help make the event a success.”
About Jarden Life Sciences:
Jarden Life Sciences is a leader in the design of thermal packaging solutions, with capabilities in developing customized primary and secondary packaging as well as off-the-shelf solutions. Jarden Life Sciences offers a rich pool of resources, including specialists in thermal science, logistics, applied materials, and engineering, as well as our global resources to offer the industry’s smartest packaging solutions. Connect with Jarden Life Sciences on Twitter @JardenLS and on LinkedIn, at https://www.linkedin.com/company/10107041
About IQPC:
IQPC produces 1,500 global events that are custom-tailored to the unique needs of business executives. Founded in 1973, IQPC leverages an office network that spans six continents and a wealth of intellectual capital to provide an unparalleled portfolio of conferences and seminars. For more information, please visit http://www.iqpc.com
Contact:
Lauren Miller
Marketing Manager
(646) 454-4559
Lauren.Miller@IQPC.com
The approval and increasing use of biological pharmaceuticals has propelled the pharmaceutical and supply chain management industries forward. These biologic drugs treat diabetes and cancer, as well as vaccinate against infectious diseases – providing new treatment options for certain patient populations. However, despite advances across the supply chain, these drugs remain vulnerable throughout the last mile.
This paper identifies the challenges of temperature-sensitive drug transportation and evaluates systems available to help reduce variability in order to preserve product quality and improve business efficiencies.
READ WHITE PAPER
ACTIVE TEMPERATURE-CONTROL SYSTEMS DECREASE VARIABILITY IN PHARMACEUTICAL SAMPLING
Fishers, IN, October 5, 2015 – Jarden Life Sciences today published a white paper discussing available strategies to help to reduce risk and variability in temperature-sensitive pharmaceutical sampling. The paper outlines the advantages of active systems for temperature assurance, which offer decreased risk, increased potential for return-on-investment, and improved efficiencies for temperature-sensitive pharmaceutical sampling when compared to passive systems.
Download a complimentary copy of the white paper, “Eliminating Variability: The Solution to Temperature-Sensitive Pharmaceutical Sampling.”
In the white paper, Jarden Life Sciences highlights the growing number of biologic pharmaceuticals as a contributing factor to the need for reliable methods of distributing temperature-sensitive products in the last mile of the supply chain.
“As the demand for and prevalence of biologic drugs increases, so does the need for effective, efficient and compliant solutions for distributing temperature-sensitive drug samples,” said Scott Dyvig, Program Manager, Packaging Engineering and Technical Services at Jarden Life Sciences. “Active temperature-control systems, like Jarden Life Sciences’ Envirocooler™ ActiVault™, offer a reliable and consistent temperature environment for the last mile of product distribution, increasing efficiencies and reducing costs over time.”
Dyvig will delve further into temperature-sensitive pharmaceutical sampling this week during the 13th Annual Cold Chain GDP & Temperature Management Logistics Global Forum, where he will host a workshop on “Best Practices in Sales Representative Sampling” to address the decision-making process relative to packaging and handling temperature-sensitive product samples. The Jarden Life Sciences white paper on temperature-sensitive pharmaceutical sampling provides insight into:
- The Impact of Biologic Drug Development on Product Sampling
- Active vs. Passive Temperature-Control Systems: Risks and Rewards
- Active Systems as a Business Solution
- Key Elements in the Last Mile of the Cold Chain Distribution Process
The alternative to active systems are passive cooling systems, which require additional steps to set up and maintain and are more vulnerable to human operator error when creating the cooling environment needed to sustain the temperature range for certain pharmaceuticals, such as biologics. They are also susceptible to external factors that may impact product efficacy. Active systems, in contrast, rely on a power source that can provide a more reliable and consistent temperature for the transport of biologic samples, substantially decreasing the number of steps taken by the user and reducing variability caused by external environmental changes.
Jarden Life Sciences’ Envirocooler ActiVault enables pharmaceutical companies to deliver temperature-sensitive products to healthcare providers efficiently.
The Envirocooler ActiVault helps sales representatives protect the safety, efficacy and integrity of samples. It can also lead to a potential of more than 38,000 minutes of sales time saved over a five-year span when compared with passive systems, ultimately strengthening relationships with healthcare providers and improving conversion success rates associated with product launches.
“Hand sampling is critical to business success for pharmaceutical companies and their temperature-sensitive products,” continued Dyvig. “Using an active system during hand sampling reduces variability and therefore helps ensure that sample product efficacy and potency are not compromised.”
About Jarden Life Sciences
Jarden Life Sciences is a leader in the design of thermal packaging solutions, with capabilities in developing customized primary and secondary packaging as well as off-the-shelf solutions. Jarden Life Sciences offers a rich pool of resources, including specialists in thermal science, logistics, applied materials, and engineering, as well as the global resources of Jarden Corporation to offer the industry’s smartest packaging solutions. Connect with Jarden Life Sciences on Twitter @JardenLS and on LinkedIn, athttps://www.linkedin.com/company/10107041.
About Jarden Corporation
Jarden Corporation is a diversified, global consumer products company with a portfolio of over 120 trusted, authentic brands. Jarden’s record of strong financial performance and organic growth is supported by a focused operating culture coupled with value enhancing acquisitions and shareholder focused capital allocation. Jarden operates in three primary business segments through a number of well recognized brands, including: Branded Consumables: Ball®, Bee®, Bernardin®, Bicycle®, Billy Boy®, Crawford®, Diamond®, Envirocooler®, Fiona®, First Alert®, First Essentials®, Hoyle®, Kerr®, Lehigh®, Lifoam®, Lillo®, Loew-Cornell®, Mapa®, Millefiori®, NUK®, Pine Mountain®, Quickie®, Spontex®, Tigex®, Waddington®, Yankee Candle® and YOU®; Outdoor Solutions: Abu Garcia®, AeroBed®, Berkley®, Campingaz® and Coleman®, Dalbello®, ExOfficio®, Fenwick®, Greys®, Gulp!®, Hardy®, Invicta®, K2®, Marker®, Marmot®, Mitchell®, PENN®, Rawlings®, Shakespeare®, Squadra®, Stearns®, Stren®, Trilene®, Völkl® and Zoot®; and Consumer Solutions: Bionaire®, Breville®, Cadence®, Crock-Pot®, FoodSaver®, Health o meter®, Holmes®, Mr. Coffee®, Oster®, Patton®, Rainbow®, Rival®, Seal-a-Meal®, Sunbeam®, VillaWare® and White Mountain®. Headquartered in Florida, Jarden ranks #348 on the Fortune 500 and has over 35,000 employees worldwide. For further information about Jarden, please visit www.jarden.com.
For media inquiries:
Casey Myburgh
Casey.Myburgh@Ketchum.com
202-835-8876
Jarden Life Sciences today published a white paper discussing available strategies to help to reduce risk and variability in temperature-sensitive pharmaceutical sampling. The paper outlines the advantages of active systems for temperature assurance, which offer decreased risk, increased potential for return-on-investment, and improved efficiencies for temperature-sensitive pharmaceutical sampling when compared to passive systems.
Download a complimentary copy of the white paper, “Eliminating Variability: The Solution to Temperature-Sensitive Pharmaceutical Sampling.”
In the white paper, Jarden Life Sciences highlights the growing number of biologic pharmaceuticals as a contributing factor to the need for reliable methods of distributing temperature-sensitive products in the last mile of the supply chain.
“As the demand for and prevalence of biologic drugs increases, so does the need for effective, efficient and compliant solutions for distributing temperature-sensitive drug samples,” said Scott Dyvig, Program Manager, Packaging Engineering and Technical Services at Jarden Life Sciences. “Active temperature-control systems, like Jarden Life Sciences’ Envirocooler™ ActiVault™, offer a reliable and consistent temperature environment for the last mile of product distribution, increasing efficiencies and reducing costs over time.”
Dyvig will delve further into temperature-sensitive pharmaceutical sampling this week during the 13th Annual Cold Chain GDP & Temperature Management Logistics Global Forum, where he will host a workshop on “Best Practices in Sales Representative Sampling” to address the decision-making process relative to packaging and handling temperature-sensitive product samples. The Jarden Life Sciences white paper on temperature-sensitive pharmaceutical sampling provides insight into:
- The Impact of Biologic Drug Development on Product Sampling
- Active vs. Passive Temperature-Control Systems: Risks and Rewards
- Active Systems as a Business Solution
- Key Elements in the Last Mile of the Cold Chain Distribution Process
The alternative to active systems are passive cooling systems, which require additional steps to set up and maintain and are more vulnerable to human operator error when creating the cooling environment needed to sustain the temperature range for certain pharmaceuticals, such as biologics. They are also susceptible to external factors that may impact product efficacy. Active systems, in contrast, rely on a power source that can provide a more reliable and consistent temperature for the transport of biologic samples, substantially decreasing the number of steps taken by the user and reducing variability caused by external environmental changes.
Jarden Life Sciences’ Envirocooler ActiVault enables pharmaceutical companies to deliver temperature-sensitive products to healthcare providers efficiently.
The Envirocooler ActiVault helps sales representatives protect the safety, efficacy and integrity of samples. It can also lead to a potential of more than 38,000 minutes of sales time saved over a five-year span when compared with passive systems, ultimately strengthening relationships with healthcare providers and improving conversion success rates associated with product launches.
“Hand sampling is critical to business success for pharmaceutical companies and their temperature-sensitive products,” continued Dyvig. “Using an active system during hand sampling reduces variability and therefore helps ensure that sample product efficacy and potency are not compromised.”
About Jarden Life Sciences
Jarden Life Sciences is a leader in the design of thermal packaging solutions, with capabilities in developing customized primary and secondary packaging as well as off-the-shelf solutions. Jarden Life Sciences offers a rich pool of resources, including specialists in thermal science, logistics, applied materials, and engineering, as well as the global resources of Jarden Corporation to offer the industry’s smartest packaging solutions. Connect with Jarden Life Sciences on Twitter @JardenLS and on LinkedIn, at https://www.linkedin.com/company/10107041.
About Jarden Corporation
Jarden Corporation is a diversified, global consumer products company with a portfolio of over 120 trusted, authentic brands. Jarden’s record of strong financial performance and organic growth is supported by a focused operating culture coupled with value enhancing acquisitions and shareholder focused capital allocation. Jarden operates in three primary business segments through a number of well recognized brands, including: Branded Consumables: Ball®, Bee®, Bernardin®, Bicycle®, Billy Boy®, Crawford®, Diamond®, Envirocooler®, Fiona®, First Alert®, First Essentials®, Hoyle®, Kerr®, Lehigh®, Lifoam®, Lillo®, Loew-Cornell®, Mapa®, Millefiori®, NUK®, Pine Mountain®, Quickie®, Spontex®, Tigex®, Waddington®, Yankee Candle® and YOU®; Outdoor Solutions: Abu Garcia®, AeroBed®, Berkley®, Campingaz® and Coleman®, Dalbello®, ExOfficio®, Fenwick®, Greys®, Gulp!®, Hardy®, Invicta®, K2®, Marker®, Marmot®, Mitchell®, PENN®, Rawlings®, Shakespeare®, Squadra®, Stearns®, Stren®, Trilene®, Völkl® and Zoot®; and Consumer Solutions: Bionaire®, Breville®, Cadence®, Crock-Pot®, FoodSaver®, Health o meter®, Holmes®, Mr. Coffee®, Oster®, Patton®, Rainbow®, Rival®, Seal-a-Meal®, Sunbeam®, VillaWare® and White Mountain®. Headquartered in Florida, Jarden ranks #348 on the Fortune 500 and has over 35,000 employees worldwide. For further information about Jarden, please visit www.jarden.com.
For media inquiries:
Casey Myburgh
Casey.Myburgh@Ketchum.com
202-835-8876